Takiron Launches High-strength, Biodegradable Osteosynthesis Material in Europe.Tokyo, Japan, Oct 24, 2005 - (JCNN JCNN Japan Corporate News Network ) - Takiron announced on October 24 that it has obtained CE Mark approval on Osteotrans, its proprietary biodegradable material for osteosynthesis, as of August 24. The company began shipping it to Swiss medical appliance company Medartis in mid-October. The first such product that has been exported from Japan, Osteotrans is distributed under the trade name of Super Fixsorb in Japan. The newly-approved material, which is made of a composite of absorbable hydroxyapatite hydroxyapatite /hy·droxy·ap·a·tite/ (-ap´ah-tit) an inorganic calcium-containing constituent of bone matrix and teeth, imparting rigidity to these structures. (HA) and poly-L-lactide (PLLA PLLA Poly-L-Lactide Acid PLLA Participatory Landscape Lifescape Appraisal PLLA PHP Library for Location Applications ), has superior biocompatibility biocompatibility the quality of not having toxic or injurious effects on biological systems. biocompatibility 1. The extent to which a foreign, usually implanted, material elicits an immune or other response in a recipient 2. and strength. The material is expected to be used for a wide range of applications, from orthopedic to oral to cerebral surgery. Starting this fall, Medartis started to introduce Osteotrans to hospitals in Europe Lists of hospitals for each country in Europe.
Going forward, Takiron plans to market Osteotrans in the US upon receiving the FDA's approval. The company expects to generate more than 1 billion yen ($8.7 mil) in overseas sales of Osteotrans three years from now. Source: JCN http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion